Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 26, 2025
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell
After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
If at first you don’t succeed: Testing outcomes of second CAR T-cell infusions
From the Turtle group and collaborators, Clinical Research Division
Antibody blocks Epstein-Barr virus in preclinical trial
Hutch-discovered protein blocks virus linked to cancers, mono, autoimmune diseases
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
CAR T cells manufacture upgrades
From the Till lab, Clinical Research Division
One family, two sides of cancer
Basic scientist Dr. Wenying Shou’s parents were both treated for — and cured of — their cancers. The similarities end there.
Mustang Bio licenses Fred Hutch CD20 CAR-T immunotherapy for lymphoma trial
New type of immunotherapy for people with B-cell non-Hodgkin lymphoma
Integrated approach to overcome pathogen-associated malignancies
Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents
Good News: Dr. Betz Halloran wins award in Rome; Hutch nominated for SLU nonprofit of the year; Obliteride amassed $2.4M in donations
Celebrating faculty and staff achievements
New approach aims to restore immune-powering B cells in cancer patients following successful immunotherapy with CAR T cells
New approach, not yet tested in humans, aims to restore immune-powering B cells in cancer patients following successful CAR T-cell therapy
Patients with advanced lymphoma in remission after T-cell therapy
New study: 7 of 11 trial participants who got two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission
Bike ride to raise cancer funds is personal for 3 'Obliteriders'
For Nancy Evans, Brian Tracy and Dr. Jerry Radich, this weekend’s fundraising bike ride is personal
Can Timothy Ray Brown’s HIV cure be repeated?
'Patient B' joined a Boston research study to find out: Gary Steinkohl’s story — and legacy